(MENAFN- America News Hour) MarketStudy Report Has Added A New Report On Vaccines Market That Provides A
Comprehensive Review Of This Industry With Respect To The Driving Forces
Influencing The Market Size. Comprising The Current And Future Trends Defining
The Dynamics Of This Industry Vertical, This Report Also Incorporates The
Regional Landscape Of Vaccines Market In Tandem With Its Competitive Terrain.
The global vaccines market is expected to reach US$ 64,538.4
Mn in 2027 from US$ 36,998.8 in 2018. The market is estimated to grow with a
CAGR of 6.5% from 2019-2027.
Request a sample of this premium report titled at:https://www.marketstudyreport.com/request-a-sample/2096046
The vaccines market by technology is segmented into
Recombinant vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated
Vaccines, and Toxoid Vaccines. In 2018, the conjugate vaccines segment held a
largest market share of 65.1% of the vaccines market, By Technology. This
segment is also expected to dominate the market in 2027 as they are the most
effective forms of immunization, used to prevent diseases in both infants and
adults. Moreover, the similar segment is anticipated to also witness the
fastest growth rate of 6.7% during the forecast period, 2019 to 2027 owing to
the increasing demand for drugs to treat the disease.
The major driving factors are rising prevalence of
infectious diseases, growing focus on immunization programs, and increasing
support for vaccine development are expected to boost the market growth over
the years. However, soaring prices of the vaccines and complexity and cost of
vaccine manufacturing are likely to pose a negative impact on the market
growth. On the other hand, robust pipeline of vaccines is likely to have a
positive impact on the growth of the global vaccines market in the coming
years. In the current era, there are increasing concerns of spread of
infectious diseases with the changing environment. These emerging infectious
diseases are a burden on public health but have also an impact on global
economies. The new diseases such as HIV, hepatitis, dengue have attracted a
huge concern for the government of the respective countries.
There is also resurgence of diseases which seemed to be
under control such as malaria, cholera and many more. According to the Centers
for Disease control and Prevention in 2015, 16.8 million people in the US
visited hospitals due to infectious and parasitic diseases. In Africa, chronic
viral hepatitis affects around 70 million Africans (60 million with Hepatitis B
and 10 million with Hepatitis C). The disease impacts the most important part
of the African population i.e. youths and earning African population which are causing
tremendous rise in financial debts incurred for the treatment of advanced liver
diseases and emotional distress. Thus the growing global prevalence of
infectious diseases are expected to encourage the leading market players for
the development of new and effective drugs and vaccines.
The global vaccines market on the patient type is segmented
into pediatric patients and adult patients. In 2018, the pediatric segment held
a largest market share of 70.0% of the vaccines market, by patient type. This
segment is also expected to dominate the market in 2027 as external
immunization is necessary for the new borns. Moreover, vaccines have helped the
children in staying healthy and been successful to save millions of lives for
more than 50 years.
Some of the major primary and secondary sources for vaccines
included in the report are World Health Organization (WHO), European Medical
Agency (EMA), Advisory Committee on Immunization Practices (ACIP), China Food
and Drug Administration (CFDA), Council of Scientific and Industrial Research
(CSIR), French Scientific Research Centre (FSRC), and others.
Request a discount on standard prices of this premium report titled at:https://www.marketstudyreport.com/check-for-discount/2096046
SOME POINTS OF TABLE OF CONTENTS:
5. GLOBAL VACCINES MARKET - KEY MARKET DYNAMICS
5.1 KEY MARKET DRIVERS
5.1.1 Rising Prevalence of Infectious Diseases
5.1.2 Growing Focus on Immunization Programs
5.1.3 Increasing Support for Vaccine Development
5.2 KEY MARKET RESTRAINTS
5.2.1 The Complexity And Cost of Vaccine Manufacturing
5.2.2 Soaring Costs of Vaccines
5.3 KEY MARKET OPPORTUNITIES
5.3.1 Robust Pipeline of Vaccines
5.4 FUTURE TRENDS
5.4.1 New Vaccine Delivery Systems
5.5 IMPACT ANALYSIS
6. VACCINES MARKET - GLOBAL ANALYSIS
6.1 GLOBAL VACCINES MARKET REVENUE FORECASTS AND ANALYSIS
6.2 GLOBAL VACCINES MARKET, BY GEOGRAPHY - FORECASTS AND
ANALYSIS
6.3 PERFORMANCE OF KEY PLAYERS
6.3.1 GlaxoSmithKline plc
6.3.2 Sanofi
7. VACCINES MARKET ANALYSIS AND FORECASTS TO 2027 -
TECHNOLOGY
7.1 OVERVIEW
7.2 TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$
MN)
7.3 RECOMBINANT VACCINES MARKET
7.3.1 Overview
7.3.2 Recombinant Vaccines Market Revenue and Forecast to
2027 (US$ Mn)
7.4 CONJUGATE VACCINES MARKET
7.4.1 Overview
7.4.2 Conjugate Vaccines Market Revenue and Forecast to 2027
(US$ Mn)
7.5 LIVE ATTENUATED VACCINES MARKET
7.5.1 Overview
7.5.2 Live Attenuated Vaccines Market Revenue and Forecast
to 2027 (US$ Mn)
7.6 INACTIVATED VACCINES MARKET
7.6.1 Overview
7.6.2 Inactivated Vaccines Market Revenue and Forecast to
2027 (US$ Mn)
7.7 TOXOID VACCINES MARKET
7.7.1 Overview
7.7.2 Toxoid Vaccines Market Revenue and Forecast to 2027
(US$ Mn)
8. VACCINES MARKET ANALYSIS AND FORECASTS TO 2027 - DISEASE
INDICATION
8.1 OVERVIEW
8.2 DISEASE INDICATION MARKET REVENUE AND FORECASTS ANALYSIS
(US$ MN)
8.3 DTP (DIPHTHERIA, TETANUS, AND PERTUSSIS) MARKET
8.3.1 Overview
8.3.2 DTP (Diphtheria, Tetanus, And Pertussis) Market
Revenue and Forecast to 2027 (US$ Mn)
8.4 INFLUENZA MARKET
8.4.1 Overview
8.4.2 Influenza Market Revenue and Forecast to 2027 (US$ Mn)
8.5 HEPATITIS MARKET
8.5.1 Overview
8.5.2 Hepatitis Market Revenue and Forecast to 2027 (US$ Mn)
8.6 RESPIRATORY SYNCYTIAL VIRUS (RSV) MARKET
8.6.1 Overview
8.6.2 Respiratory Syncytial Virus (RSV) Market Revenue and
Forecast to 2027
(US$ Mn)
8.7 OTHER DISEASES MARKET
8.7.1 Overview
8.7.2 Other Diseases Market Revenue and Forecast to 2027
(US$ Mn)
9. VACCINES MARKET ANALYSIS AND FORECASTS TO 2027 - ROUTE OF
ADMINISTRATION
9.1 OVERVIEW
9.2 ROUTE OF ADMINISTRATION MARKET REVENUE AND FORECASTS
ANALYSIS
(US$ MN)
9.3 ORAL MARKET
9.3.1 Overview
9.3.2 Oral Market Revenue and Forecast to 2027 (US$ Mn)
9.4 INJECTABLE MARKET
9.4.1 Overview
9.4.2 Injectable Market Revenue and Forecast to 2027 (US$
Mn)
9.5 OTHER ROUTES OF ADMINISTRATION MARKET
9.5.1 Overview
9.5.2 Other Routes of Administration Market Revenue and
Forecast to 2027
(US$ Mn)
10. VACCINES MARKET ANALYSIS AND FORECASTS TO 2027 - PATIENT
TYPE
10.1 OVERVIEW
10.2 PATIENT TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$
MN)
10.3 PEDIATRIC MARKET
10.3.1 Overview
10.3.2 Pediatric Market Revenue and Forecast to 2027 (US$
Mn)
10.4 ADULTS MARKET
10.4.1 Overview
10.4.2 Adults Market Revenue and Forecast to 2027 (US$ Mn)
11. VACCINES MARKET REVENUE AND FORECASTS TO 2027 -
GEOGRAPHICAL ANALYSIS
11.1 NORTH AMERICA VACCINES MARKET
11.1.1 Overview
11.1.2 North America Vaccines Market Revenue And Forecasts
to 2027 (US$ Mn)
11.1.3 North America Vaccines Market Revenue And Forecasts
to 2027, By Technology (US$ Mn)
11.1.4 North America Vaccines Market Revenue And Forecasts
to 2027, By Disease Indication (US$ Mn)
11.1.5 North America Vaccines Market Revenue And Forecasts
to 2027, By Route of Administration (US$ Mn)
11.1.6 North America Vaccines Market Revenue And Forecasts
to 2027, By Patient Type (US$ Mn)
11.1.7 North America Vaccines Market Revenue And Forecasts
to 2027, By Country (%)
11.1.8 US Vaccines Market Revenue and Forecasts to 2027 (US$
Mn)
11.1.9 US Vaccines Market Revenue and Forecasts to 2027 (US$
Mn)
11.1.9.1 US Vaccines Market Revenue And Forecasts to 2027,
By Technology (US$ Mn)
11.1.9.2 US Vaccines Market Revenue And Forecasts to 2027,
By Disease Indication (US$ Mn)
11.1.9.3 US Vaccines Market Revenue And Forecasts to 2027,
By Route of Administration (US$ Mn)
Continued……………….
Questions? Get them answered viahttps://www.marketstudyreport.com/enquiry-before-buying/2096046
before
taking a buying decision on this premium report titled Vaccines Market to 2027-
Global Analysis and Forecasts by Technology (Recombinant Vaccines, Conjugate
Vaccines, Live Attenuated Vaccines, Inactivated and Subunit Vaccines, and
Toxoid Vaccines); Disease Indication (DTP (Diphtheria Tetanus toxoids and
Pertussis), Influenza, Hepatitis, Respiratory Syncytial Virus (RSV), and Other
Diseases); Route of Administration (Oral, Injectable, and Other Routes of
Administration); Patient Type (Pediatric Patients, and Adult Patients) and Geography
About Us:
Marketstudyreport.com allows you to manage and control all corporate research
purchases to consolidate billing and vendor management. You can eliminate
duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:
Website:https://www.marketstudyreport.com
Blog:https://www.marketstudyreport.com/blog
Market Study Report LLC
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
MENAFN20072019007010068ID1098779753
-MENAFN20072019007010068ID1098779753-->